Outcomes of severely ill patients with AIDS treated with efavirenz or dolutegravir: a multicenter, observational study

Outcomes of severely ill patients with AIDS treated with efavirenz or dolutegravir: a multicenter, observational study

BackgroundCurrently, integrase inhibitors (INIs)-based ART regimens are the preferred initial therapy for AIDS patients. There is scarce information on the use of dolutegravir (DTG) among late-presenter people living with HIV (PLHIV).ObjectivesTo compare the effect of DTG- or efavirenz (EFV)-based r...

Full description

Bibliographic Details
Main Authors: Carlos Brites, Marcus Lacerda, Eduardo Sprinz, Monica Bay, Gustavo Pinto, Pollyanna Azevedo, Estela Luz, Liliane Lins-Kusterer, Eduardo M. Netto
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-02-01
Series:Frontiers in Medicine
Subjects:
early mortality
advanced AIDS
dolutegravir
efavirenz
adverse (side) effects
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1302710/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2024.1302710/full

Similar Items